Background-Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is
activated by fatty acids, eicosanoids, and insulin-sensitizing thiazolidin
ediones (TZDs). The TZD troglitazone (TRO) inhibits vascular smooth muscle
cell (VSMC) proliferation and migration in vitro and in postinjury intimal
hyperplasia.
Methods and Results-Rat and human VSMCs express mRNA and nuclear receptors
for PPAR gamma 1. Three PPAR gamma ligands, the TZDs TRO and rosiglitazone
and the prostanoid 15-deoxy-Delta(12,14)-prostaglandin J2 (15d-PGJ2), all i
nhibited VSMC proliferation and migration. PPAR gamma is upregulated in rat
neointima at 7 days and 14 days after balloon injury and is also present i
n early human atheroma and precursor lesions.
Conclusions-Pharmacological activation of PPAR gamma expressed in VSMCs inh
ibits their proliferation and migration, potentially limiting restenosis an
d atherosclerosis. These receptors are upregulated during vascular injury.